Eyenovia, Inc. regained compliance with Nasdaq's minimum bid requirement of $1.00 per share as of February 20, 2025, allowing its stock to remain listed on the Nasdaq Capital Market. This follows a period of non-compliance that began on September 18, 2024, when the stock price fell below the required threshold.